23
https://pubmed.ncbi.nlm.nih.gov/38113468
Bendamustine lymphodepletion before axicabtagene ciloleucel therapy is safe, effective, and associated with reduced inflammatory cytokines and toxicities compared to standard fludarabine/cyclophosphamide lymphodepletion in patients with large B-cell lymphomas and follicular lymphoma.